Cadence Neuroscience
PrivateLast Round
Series B
May 17, 2023
Total Funding Raised
$41M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Cadence Neuroscience operates in Healthcare & Life Sciences and is based in Redmond, Washington. Its latest recorded funding round was a Series B round in May 2023.
Cadence Neuroscience is a medical technology company that develops implantable neuromodulation therapy devices to treat drug-resistant epilepsy.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Clinical Trials, Biotechnology
Business Model
B2B
Customer Profile
Hardware Sales, Hardware + Subscription, Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Cadence Neuroscience Comparables
Compare Cadence Neuroscience with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Precisis GmbH | 82% | |
| Synergia Medical | 81% | |
| NeuroPace | 79% |
For institutional investors. Book with your work email.
Cadence Neuroscience Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | May 17, 2023 | ||||
| Series A | Nov 6, 2019 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Cadence Neuroscience Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| F-Prime Capital | Series B |
| JAZZ Venture Partners | Series B, Series A |
| Epilepsy Foundation | Series A |
| Mayo Clinic Ventures | Series A |
| Angelini Ventures | Series B |
| F-Prime Capital | Series B |
| Lumira Ventures | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 25, 2026
Monthly visitors increased 141% MoM, reaching 3.1K.
- Apr 19, 2026
Monthly visitors increased 33% MoM.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- hiresSep 22, 2026
Cadence Neuroscience, Inc. appoints founder Kent Leyde as Chief Technology Officer to lead technology development, product strategy, and key external collaborations in Washington on Sep 22nd '26.
- hiresSep 22, 2026
Cadence Neuroscience, Inc. appoints medtech executive Chris Cronin as Chief Executive Officer in Washington on Sept. 22nd '26 to lead clinical execution and platform growth as it prepares to evaluate its investigational BTS system in focal drug-resistant epilepsy.
For institutional investors. Book with your work email.
Cadence Neuroscience Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Cadence Neuroscience's valuation, stock price, and market status.
Is Cadence Neuroscience a public or private company?
Cadence Neuroscience is a private company.
What is the current stock price of Cadence Neuroscience?
Cadence Neuroscience is a private company, so its shares have no public market price. Caplight tracks Cadence Neuroscience's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Cadence Neuroscience worth (valuation)?
Valuation information for Cadence Neuroscience is not publicly available.
Can I buy Cadence Neuroscience stock?
Cadence Neuroscience shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Cadence Neuroscience's last funding round?
Cadence Neuroscience's most recent funding round was Series B on May 17, 2023.
Who are the main investors in Cadence Neuroscience?
Key investors in Cadence Neuroscience include JAZZ Venture Partners.
Will Cadence Neuroscience IPO soon?
No public IPO plans have been announced for Cadence Neuroscience.
How can I track Cadence Neuroscience secondary market activity?
Caplight tracks bids, offers, and trades in Cadence Neuroscience's shares on secondary markets.